Registration
2026 CE Information
May 13 - 17, 2026

CE

20
26
Information
MUSIC CITY SCALE 2026
Nashville, TN
SCALE is THE Premier Medical Symposium for Aesthetics Providers, for Medical and Cosmetic Dermatologists, for Plastic Surgeons, and Practice Administrators. Nowhere else do you have access to such a wide variety of educational topics suited for multiple disciplines all in one meeting. With over 90+ national and international faculty at SCALE, this is your BEST chance to learn from top leaders, pioneers, and researchers in the fields of medical and cosmetic dermatology, aesthetics medicine, and plastic surgery.

Target Audience: This activity is designed for an audience of nurses, physicians, and physician assistants.

Plenary Sessions

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Review current treatment options for patients with alopecia areata including recent JAK inhibitors
  • Compare new and emerging therapies for Atopic Dermatitis (AD)
  • Compare and contrast established and novel therapies for treatment of acne
  • Review treatment options for current and emerging therapies for the treatment of actinic keratosis 
  • Discuss advances in treatment of non-melanoma skin carcinomas including rare skin tumors
  • Review new and emerging treatments for basal cell carcinoma and squamous cell carcinoma
  • Discuss application for various neurotoxins, dermal fillers, surgical and minimally invasive treatments for facial rejuvenation and elimination of submental fat
  • Compare and contrast available options for non‐invasive body contouring and reduction of cellulite with energy-based devices 
  • Recognize strategies and treatments for a diverse patient population including ethnic and gender differences
  • Discuss indications, contraindications, and properties of existing and emerging neuromodulators and dermal fillers approved for use in the US
  • Review the anatomy and injection techniques for specific regions of the face including the chin, jawline and brow
  • Discuss treatment options for molluscum contagiosum
  • Review the prevalence, severity, and impact of primary axillary hyperhidrosis and other common forms of hyperhidrosis
  • Review the prevalence, severity, and impact of hidradenitis suppurativa (HS)
  • Review treatment options for patients with hair loss
  • Review the latest advanced techniques in lasers, light, ultrasound, and radiofrequency devices
  • Identify the current and emerging therapies available to manage moderate to severe psoriasis
  • Review treatment strategies, based on knowledge of the indications, efficacy, and risks of available rosacea therapies, to achieve therapeutic goals in rosacea treatment
  • Describe advances in the management of patients with vitiligo

Commercial Support:

This activity is supported by educational grants from AbbVie Inc., Almirall, LLC, Amgen, Bausch Health US, LLC, Evolus, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, UCB, and Veradermics, Inc.
This activity is supported from in-kind support from AbbVie Inc., Evolus, Galderma Laboratories, L.P., Merz North America, Inc., Revance.

Devices 101 Workshop

This course will provide attendees with education on various types of lasers in the form of multiple educational didactic lectures.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Review the latest advanced techniques for energy-based devices to provide optimum patient outcomes and reduce complications.
  • Describe laser physics and laser safety.
  • Compare and contrast the various types of lasers.

Commercial Support: There is no commercial support for this activity.

Facial Anatomy Workshop

This course consists of four 90-minute modules focusing on toxins, upper face, middle face and lower face. Each module will include a detailed explanation of the anatomy, as seen in the cadaver, which is compared in real time to an injection in the correlating area on a live model also coupled with the use of ultrasound technology to teach enhanced safety and patient outcomes. Viewing the anatomy with the use of ultrasound and the injection technique side-by-side is a unique and impactful learning tool to enhance your understanding of safety zones and improve patient outcomes.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe the anatomy of the face in terms of volume loss and structural changes in multiple tissue layers
  • Identify the functional aspect of facial muscles including surface landmarks
  • Assess a patient’s candidacy for facial rejuvenation with neurotoxin, dermal fillers and deoxycholic acid
  • Recognize the appropriate anatomical plane for injection when using dermal fillers and deoxycholic acid
  • Differentiate among dermal filler agents
  • Distinguish between sensory and nerve anatomy
  • Perform neurotoxin, dermal filler and deoxycholic acid injections for a range of indications
  • Identify anatomical ‘danger zones’ which may result in adverse events or permanent injury if neurotoxin, dermal fillers or deoxycholic acid are injected improperly
  • Assess the benefits of utilizing ultrasound technology for guided anatomy mapping and injections

Commercial Support:
This activity is supported by educational grants from AbbVie Inc. and Evolus.
This activity is supported from in-kind support from AbbVie Inc., Evolus, Galderma Laboratories, L.P., GE Healthcare, Merz North America, Inc., and Revance.

Facial Ultrasound Imaging

In recent years aesthetics products and treatment options in injectables, devices and minimally invasive techniques have continued to dramatically increase in popularity. With the influx of new therapies, technologies and procedures in dermatology and aesthetics medicine it is imperative for aesthetics providers to remain up to date on the safety and efficacy of these products for the best patient outcomes. The Facial Ultrasound Imaging Hands on Course will provide innovative education, skills, and techniques that attendees can immediately adapt into their current practice environment to provide safe, effective, and high- level patient care. This hands-on course will teach attendees the benefits of using ultrasound technology in facial aesthetics to ensure safe and effective injection technique. The course will be led by internationally recognized experts in facial ultrasound and anatomy.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  •  Assess the benefits of utilizing ultrasound technology for guided anatomy mapping and injections to prevent complications.
  • Review how to perform an Ultrasound examination of the face and injecting and identifying fillers under Ultrasound guidance.

Commercial Support: This activity is supported with in-kind support from GE Healthcare.

Hands-on Workshop on the Art and Science of Combination Therapy: Advanced Treatment Planning & Injection Techniques

This immersive workshop is designed to move beyond injection technique and into the art and strategy of combination therapy. Attendees will learn how to develop comprehensive, patient-specific treatment plans by integrating neuromodulators, hyaluronic acid fillers, and biostimulatory agents for optimal facial and neck rejuvenation. Participants will explore how to assess patient anatomy, prioritize treatment goals, and determine when, and how, to layer modalities for natural, balanced outcomes. Participants will then participate in a live patient assessment and treatment demonstration, with real-time insights into product selection, injection techniques, and procedural nuances.
The workshop will conclude with a hands-on training experience, where participants will practice advanced injection techniques under the direct guidance of expert faculty in a highly personalized, small-group setting. Participation is limited to 25 attendees to ensure an intimate, high-impact learning environment with individualized training.
Note: Attendees must be licensed in the state of Tennessee to be able to inject. Attendees may observe the workshop without injecting.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe how to develop comprehensive, patient-specific treatment plans by integrating neuromodulators, hyaluronic acid fillers, and biostimulatory agents for optimal facial and neck rejuvenation.
  • Explore how to assess patient anatomy, prioritize treatment goals, and determine when, and how, to layer modalities for natural, balanced outcomes

Commercial Support:
This activity is supported by an educational grant Merz North America, Inc.
This activity is supported from in-kind support from Merz North America, Inc.

Hands-on Workshop: Optimizing Outcomes in Lower Face Rejuvenation with Next-Gen Hyaluronic Acid Fillers

This hands-on workshop is designed to provide participants with a comprehensive understanding of newly approved hyaluronic acid (HA) dermal fillers and their integration into clinical practice.
The session will begin with a presentation reviewing product characteristics, rheology, and clinical indications, with a focus on the treatment of nasolabial folds and mid-to-lower face volumization. Participants will gain insight into patient assessment, facial anatomy, injection planning, and complication avoidance strategies. Emphasis will be placed on evidence-based approaches to optimizing aesthetic outcomes using HA fillers. The majority of the workshop will be dedicated to supervised, small-group, hands-on injection training. Attendees will have the opportunity to refine their injection techniques under expert faculty guidance, with a focus on precision, safety, and achieving natural-looking results across commonly treated facial areas.
The workshop will conclude with a hands-on training experience, where participants will practice advanced injection techniques under the direct guidance of expert faculty in a highly personalized, small-group setting. Participation is limited to 25 attendees to ensure an intimate, high-impact learning environment with individualized training.
Note: Attendees must be licensed in the state of Tennessee to be able to inject. Attendees may observe the workshop without injecting.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

    • Describe the newly approved hyaluronic acid (HA) dermal fillers and their integration into clinical practice
    • Review product characteristics, rheology, and clinical indications, with a focus on the treatment of nasolabial folds and mid-to-lower face volumization.
    • Review patient assessment, facial anatomy, injection planning, and complication avoidance strategies in evidence-based approaches to optimizing aesthetic outcomes using HA fillers
    • Review injection techniques under expert faculty guidance, that focus on precision, safety, and achieving natural-looking results across commonly treated facial areas.

Commercial Support:
This activity is supported by an educational grant from Obagi.
This activity is supported from in-kind support from Obagi.

Accreditation

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
HMP Education is further accredited to provide CE for additional disciplines (see “Credit Types”). HMP Education designate these live activities for a maximum of (see below) CE Credits.

CE Credits

A total of up to 32 credits are offered across all live educational sessions.
Individual session credit designations are as follows:
Track 1: 24.5 credits
Track 2: 8.25 credits
Workshops:
Devices 101 workshop: 6.0 credits
Facial Anatomy Workshop: 6.25 credits
Facial Ultrasound Imaging: 1.50 credits
Hands-on Workshop on the Art and Science of Combination Therapy: Advanced Treatment Planning & Injection Techniques: 2 credits
Hands-on Workshop: Optimizing Outcomes in Lower Face Rejuvenation with Next-Gen Hyaluronic Acid Fillers: 2 credits
Please note: Sessions may run concurrently. The maximum number of credits that can be earned by an individual participant will depend on session attendance.

Credit Types

Nurse: ANCC contact hours

This continuing nursing education activity awards 32.0 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #18006 for 32.0 contact hours.

Nurse Practitioner: ACCME AMA PRA Category 1 Credits™

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
The content in this activity pertaining to pharmacology is worth 32.0 continuing education hours of pharmacotherapeutics.

Pharmacy: ACPE application-based contact hours

This live activity has been approved for a maximum of 32.0 contact hours (3.1 CEUs).
The official record of credit will be in the CPE Monitor system. Following ACPE Policy, HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and are unable to report your claimed credit after this 60-day period.

Physician: ACCME AMA PRA Category 1 Credits™

HMP Education designates this live activity for a maximum of 32.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associate/Assistant: AAPA Category 1 CME credits

CME Guidelines
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with the AAPA CME Criteria. This live activity is designated for 32.0 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.

Non-Physician Member of the Healthcare Team: Certificate of Participation

HMP Education awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credits™) to a participant who successfully completes this educational activity.

Interprofessional Continuing Education: IPCE credit for learning and change

IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 32.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

International Recognition

Visit this link for Countries and Regions have reciprocity with the ACCME.
Visit this link for additional countries that accept ACCME-accredited continuing medical education (CME).

Requirements for Credit

To be eligible for documentation of credit for each session attended, learners must participate in the activity and complete the session(s) and overall conference evaluations, and post-test(s), if applicable. Participants who complete the evaluation online within 30 days of the conference will receive documentation of credit. Your certificate may not load if you are accessing it from a smartphone, or settings of your browser do not allow for a new tab/window to open.
Once a certificate has been claimed, physicians and pharmacists may elect for credits to be submitted on their behalf to their boards via additional fields that will appear within the Claim Certificate page. Credits must be submitted through this process to be reported to the American Board of Surgery and the National Association of Boards of Pharmacy.

ADA Statement

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodation(s), please submit a request to contact the support team.

Disclosure of Relevant Financial Relationships

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to and mitigating all perceived or real relevant financial relationships (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

  1. Any individual relationship or lack thereof, and its nature, with any/all ineligible company; and
  2. Any investigational, off-label, or non–FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:

  1. All recommendations involving clinical medicine are based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
  2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.
  3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
All relevant financial relationships have been mitigated.

Disclaimers

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Privacy Policy

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2025 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.